Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study - Concepedia

Concepedia

Publication | Closed Access

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

173

Citations

36

References

2011

Year

Yearbook of Obstetrics Gynecology and Women s Health

Diabetes ManagementDiabetesPharmacologyClinical TrialsType 2PharmacotherapyDiabetes MellitusMedicineLow-dose Combination TherapyCanoe Trial

References

	Year	Citations

Page 1